176 related articles for article (PubMed ID: 34574034)
1. Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study.
Miura S; Takikawa T; Kikuta K; Hamada S; Kume K; Yoshida N; Tanaka Y; Matsumoto R; Ikeda M; Kataoka F; Sasaki A; Hatta W; Inoue J; Masamune A
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574034
[TBL] [Abstract][Full Text] [Related]
2. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
3. Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study.
Gonda M; Masuda A; Kobayashi T; Iemoto T; Kakuyama S; Ezaki T; Ikegawa T; Hirata Y; Tsumura H; Ogisu K; Nakano R; Fujigaki S; Nakagawa T; Takagi M; Yamanaka K; Sato Y; Fujita K; Furumatsu K; Kato T; Sakai A; Shiomi H; Sanuki T; Arisaka Y; Okabe Y; Toyama H; Sofue K; Kodama Y
United European Gastroenterol J; 2024 Mar; ():. PubMed ID: 38451583
[TBL] [Abstract][Full Text] [Related]
4. Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case-control study.
Koiwai A; Hirota M; Matsuura T; Itoh T; Kin R; Katayama T; Endo K; Takasu A; Kogure T; Murakami K; Satoh K
JGH Open; 2023 Jun; 7(6):445-452. PubMed ID: 37359111
[TBL] [Abstract][Full Text] [Related]
5. Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype.
Nakahodo J; Kikuyama M; Fukumura Y; Horiguchi SI; Chiba K; Tabata H; Suzuki M; Kamisawa T
Pancreatology; 2022 Dec; 22(8):1148-1158. PubMed ID: 36273992
[TBL] [Abstract][Full Text] [Related]
6. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study.
Hoogenboom SA; Engels MML; Chuprin AV; van Hooft JE; LeGout JD; Wallace MB; Bolan CW
Abdom Radiol (NY); 2022 Dec; 47(12):4160-4172. PubMed ID: 36127473
[TBL] [Abstract][Full Text] [Related]
8. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients.
Hoogenboom SA; Bolan CW; Chuprin A; Raimondo MT; van Hooft JE; Wallace MB; Raimondo M
Pancreatology; 2021 Mar; 21(2):428-433. PubMed ID: 33485792
[TBL] [Abstract][Full Text] [Related]
10. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
11. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
12. A case of high-grade pancreatic intraepithelial neoplasia diagnosed based on focal pancreatic parenchymal atrophy after acute pancreatitis.
Inomata N; Kobayashi T; Masuda A; Masuda S; Ashina S; Gonda M; Abe S; Yamakawa K; Tsujimae M; Tanaka T; Yamada Y; Tanaka S; Kakihara M; Nakano R; Ikegawa T; Sakai A; Shiomi H; Kannzawa M; Toyama H; Itoh T; Fukumoto T; Kodama Y
Clin J Gastroenterol; 2020 Dec; 13(6):1338-1342. PubMed ID: 32803643
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis.
Takayanagi T; Sekino Y; Kasuga N; Ishii K; Nagase H; Nakajima A
Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900107
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Cui W; Chen R; Guo K; Zhang H; Chen S; Wang Z
Cancer Manag Res; 2019; 11():7857-7866. PubMed ID: 31686905
[TBL] [Abstract][Full Text] [Related]
16. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
17. Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma.
Barat M; Aldhaheri R; Dohan A; Fuks D; Kedra A; Hoeffel C; Oudjit A; Coriat R; Barret M; Terris B; Marchese U; Soyer P
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206263
[No Abstract] [Full Text] [Related]
18. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
[TBL] [Abstract][Full Text] [Related]
19. Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct.
Miura S; Kume K; Kikuta K; Hamada S; Takikawa T; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Furukawa T; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Sep; 252(1):63-71. PubMed ID: 32879148
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
